BR112018072141A8 - método para manter homeostase de ferro com shogaóis - Google Patents

método para manter homeostase de ferro com shogaóis Download PDF

Info

Publication number
BR112018072141A8
BR112018072141A8 BR112018072141A BR112018072141A BR112018072141A8 BR 112018072141 A8 BR112018072141 A8 BR 112018072141A8 BR 112018072141 A BR112018072141 A BR 112018072141A BR 112018072141 A BR112018072141 A BR 112018072141A BR 112018072141 A8 BR112018072141 A8 BR 112018072141A8
Authority
BR
Brazil
Prior art keywords
shogaols
iron homeostasis
maintain iron
iron overload
maintain
Prior art date
Application number
BR112018072141A
Other languages
English (en)
Other versions
BR112018072141B8 (pt
BR112018072141B1 (pt
BR112018072141A2 (pt
Inventor
Badmaev Vladimir
Original Assignee
Badmaev Vladimir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Badmaev Vladimir filed Critical Badmaev Vladimir
Publication of BR112018072141A2 publication Critical patent/BR112018072141A2/pt
Publication of BR112018072141A8 publication Critical patent/BR112018072141A8/pt
Publication of BR112018072141B1 publication Critical patent/BR112018072141B1/pt
Publication of BR112018072141B8 publication Critical patent/BR112018072141B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

composição de shogaóis e compostos relacionados da família zingiberaceae de plantas para saúde de metabolismo de ferro melhorada e prevenção de sobrecarga de ferro em pacientes com necessidade de abordagem nutricional e/ou terapêutica para melhorar sobrecarga de ferro.
BR112018072141A 2016-04-27 2017-04-26 Método para manter homeostase de ferro com shogaóis BR112018072141B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662328499P 2016-04-27 2016-04-27
US62/328,499 2016-04-27
PCT/US2017/029622 WO2017189717A1 (en) 2016-04-27 2017-04-26 Method maintaining iron homeostasis with shogaols

Publications (4)

Publication Number Publication Date
BR112018072141A2 BR112018072141A2 (pt) 2019-02-12
BR112018072141A8 true BR112018072141A8 (pt) 2019-08-20
BR112018072141B1 BR112018072141B1 (pt) 2022-11-29
BR112018072141B8 BR112018072141B8 (pt) 2022-12-20

Family

ID=60161077

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018072141A BR112018072141B8 (pt) 2016-04-27 2017-04-26 Método para manter homeostase de ferro com shogaóis

Country Status (10)

Country Link
US (1) US10864174B2 (pt)
EP (1) EP3448405B1 (pt)
JP (1) JP7010454B2 (pt)
KR (1) KR102405111B1 (pt)
CN (1) CN109414468B (pt)
BR (1) BR112018072141B8 (pt)
CA (1) CA3022493C (pt)
NZ (1) NZ748511A (pt)
WO (1) WO2017189717A1 (pt)
ZA (1) ZA201807955B (pt)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760010A (en) 1995-01-01 1998-06-02 Klein; Ira Method of treating liver disorders with a macrolide antibiotic
CN1056768C (zh) * 1996-10-11 2000-09-27 赵云涛 治疗各种自身免疫性疾病的中成药及其备制方法
US8614204B2 (en) 2003-06-06 2013-12-24 Fibrogen, Inc. Enhanced erythropoiesis and iron metabolism
WO2005082459A2 (en) * 2004-02-27 2005-09-09 Japan Tobacco Inc. Method of decreasing blood cells
WO2006073042A1 (ja) 2005-01-05 2006-07-13 Toagosei Co., Ltd. Ｎｒｆ２依存遺伝子の活性化剤
PT2144604E (pt) 2007-02-28 2011-10-19 Conatus Pharmaceuticals Inc Métodos para o tratamento da hepatite c viral crónica utilizando ro-113-0830
US9844521B2 (en) * 2008-11-19 2017-12-19 University-Industry Cooperation Group Of Kyung Hee University Pharmaceutical composition comprising ginger extract or shogaol
ES2731609T3 (es) * 2012-11-01 2019-11-18 Univ California Polipéptidos ERFE y eritroferrona y métodos de regulación del metabolismo del hierro
KR102218494B1 (ko) * 2013-03-15 2021-02-19 인트린식 라이프사이언시스, 엘엘씨 항-헵시딘 항체 및 그의 용도
JP6158645B2 (ja) 2013-08-28 2017-07-05 花王株式会社 ショウガ抽出処理物の製造方法
JP6531892B2 (ja) 2014-01-18 2019-06-19 池田食研株式会社 香辛料加工物の製造方法
JP6429705B2 (ja) 2015-03-30 2018-11-28 株式会社エヌ・エル・エー 血中中性脂肪低減用組成物及び血中中性脂肪低減用機能性食品

Also Published As

Publication number Publication date
US10864174B2 (en) 2020-12-15
BR112018072141B8 (pt) 2022-12-20
EP3448405A1 (en) 2019-03-06
WO2017189717A8 (en) 2019-01-10
EP3448405B1 (en) 2024-07-03
BR112018072141B1 (pt) 2022-11-29
CN109414468A (zh) 2019-03-01
JP2019515034A (ja) 2019-06-06
CA3022493A1 (en) 2017-11-02
US20190133967A1 (en) 2019-05-09
BR112018072141A2 (pt) 2019-02-12
CA3022493C (en) 2023-05-23
ZA201807955B (en) 2021-06-30
CN109414468B (zh) 2021-09-10
JP7010454B2 (ja) 2022-01-26
KR20180137553A (ko) 2018-12-27
NZ748511A (en) 2023-05-26
KR102405111B1 (ko) 2022-06-02
WO2017189717A1 (en) 2017-11-02
EP3448405A4 (en) 2019-12-11

Similar Documents

Publication Publication Date Title
TR201910765T4 (tr) Bitkisel hülasaların bir karışımını veya bu bitkilerde mevcut moleküllerin bir karışımını içeren bileşim ve karbonhidrat ve/veya lipit metabolizmasını etkilemek için kullanımı.
CY1122344T1 (el) Blautia stercosis και wexlerae για χρηση στην θεραπευτικη αγωγη φλεγμονωδων και αυτοανοσων νοσων
MX2020001513A (es) Agentes de union a clec9a y su uso.
BR112017007975A2 (pt) composições e métodos para o tratamento de disfunção das glândulas meibomianas
SG10201808102WA (en) Bicyclic heterocycle compounds and their uses in therapy
BR112016018062A8 (pt) compostos terapêuticos, composição farmacêutica e usos
BR112015029611A2 (pt) composições para uso em ruptura de cartilagem
MX370792B (es) Composiciones para usarse en el tratamiento de cáncer.
BR112018003967A2 (pt) tratamento de hipersensibilidade à picada de inseto
MX356755B (es) Compuestos de tipo fumagilol y metodos para su elaboración y uso.
BR112018003745A2 (pt) composições que compreendem um composto de urolitina
MX2018008645A (es) Derivados de 8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano.
BR112018003780A2 (pt) composições que compreendem um composto de urolitina
MA40427A (fr) Composition comprenant des substances naturelles et/ou des extraits
EP3185862A4 (en) PROTECTIVE METALOTHION ANALOG COMPOUNDS, THEIR COMPOSITIONS AND USE THEREOF IN THE TREATMENT OF PATHOGENIC DISEASES
MX2023007706A (es) Nanoparticulas para su uso como vacuna terapeutica.
NZ745187A (en) 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
BR112016015997A2 (pt) ?composições farmacêuticas que compreendem 15- hepe e métodos para tratar asma e distúrbios pulmonares com o uso das mesmas?
BR112017024163A2 (pt) compostos bicíclicos
EA201792085A1 (ru) Смешанные дисульфидные конъюгаты тиенопиридиновых соединений и их применение
MX2018000092A (es) Nuevo lipolantipeptido biciclico, preparacion y uso como agente antimicrobiano.
MX370436B (es) Composicion farmaceutica para usarse en el tratamiento o la prevencion de deficiencias de vitaminas y minerales en pacientes que han sido sometidos a cirugia de derivacion gastrica.
EA033297B1 (ru) Терапевтические и питательные композиции для функциональных нарушений работы пищеварительной системы
BR112018072141A8 (pt) método para manter homeostase de ferro com shogaóis
BR112016029619A2 (pt) novas fluoroquinolonas e sesu usos no tratamento de infecções bacterianas

Legal Events

Date Code Title Description
B25E Requested change of name of applicant rejected

Owner name: VLADIMIR BADMAEV (US)

Free format text: INDEFERIDO O PEDIDO DE CORRECAO DO NOME CONTIDO NA PETICAO 870190069455 DE 22/07/2019, EM VIRTUDE DO PEDIDO JA ESTAR EM NOME DO INTERESSADO.

B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 26/04/2017, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REF. RPI 2708 DE 29/11/2022 QUANTO AO TITULAR.